Share Buybacks
Vertex Pharmaceuticals Share Buybacks decreased by 88.0% to $128.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 69.3%, from $417.90M to $128.40M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 9.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Large repurchases signal that management believes the stock is undervalued or that they have excess cash with no better internal investment opportunities.
Detailed definition
The cash spent by a company to buy back its own shares from the open market. This reduces the total number of shares out...
Peer comparison
Highly profitable tech giants often prioritize repurchases over dividends due to tax efficiencies and the impact on EPS.
cf_share_repurchasesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $632.27M | $368.18M | $0.00 | $0.00 | $0.00 | $0.00 | $132.80M | $28.30M | $117.00M | $149.50M | $131.20M | $320.30M | $307.70M | $417.90M | $426.10M | $391.80M | $1.07B | $128.40M |
| QoQ Change | — | — | -41.8% | -100.0% | — | — | — | — | -78.7% | +313.4% | +27.8% | -12.2% | +144.1% | -3.9% | +35.8% | +2.0% | -8.0% | +173.4% | -88.0% |
| YoY Change | — | — | — | — | — | -100.0% | -100.0% | — | — | — | — | -1.2% | >999% | +163.0% | +179.5% | +224.8% | +22.3% | +248.1% | -69.3% |
Share Buybacks at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's share buybacks?
- Vertex Pharmaceuticals (VRTX) reported share buybacks of $128.40M in Q4 2025.
- How has Vertex Pharmaceuticals's share buybacks changed year-over-year?
- Vertex Pharmaceuticals's share buybacks decreased by 69.3% year-over-year, from $417.90M to $128.40M.
- What is the long-term trend for Vertex Pharmaceuticals's share buybacks?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's share buybacks has grown at a 9.1% compound annual growth rate (CAGR), from $1.43B to $2.02B.
- What does share buybacks mean?
- The money a company spends to buy back its own stock.